Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.
Trace Machina is a company that specializes in the development and maintenance of simulation infrastructure.
Mindset assists those with a mental illness and their caregivers in applying for Social Security Disability benefits.
Abnormal AI is the leading AI-native human behavior security platform.
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.
Hyzon Motors is a global supplier of hydrogen fuel-cell powered commercial vehicles.
Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.
TS Conductor specializes in high-performance conductors that increase the ampacity of electric transmission and distribution.
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
GrayMatter Robotics provides AI-powered robotic solutions that enhance productivity and efficiency for high-mix manufacturers.
CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.
WeWork is a platform for creators that transforms buildings into dynamic environments for creativity, focus, and collaboration.
Finvero is a fintech company, operating a consumer Lending MarketPlace Platform (SaaS format) connecting merchants, shoppers and lenders.
Arcadia is a climate software and data company that specializes in decarbonizing the electric grid.
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
BetterUp provides AI and human coaching to improve leadership, management, and employee performance across organizations.
Binkey is a financial technology company that helps merchants to accepts FSA and HSA as a form of payment.
Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Caraway is providing college women+ with integrated mental, reproductive, and physical healthcare.
Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.
Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.
Wellington Management has invested in 278 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Wellington Management's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Therapeutics, Medical. The firm invests across 49 different industry categories.
Among tracked funding rounds, WeWork received $450.0M in a Post Ipo Equity round. Wellington Management's total known invested capital is $59.2B.
Wellington Management's average investment size is $270.5M across its portfolio of 278 companies.
Recent Wellington Management portfolio additions include Ventyx Biosciences, Trace Machina, Mindset, Abnormal AI, MBX Biosciences. These companies were founded in 2020 or later.